These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17938192)

  • 21. Antifungal activity of amphotericin B, caspofungin and posaconazole on Candida albicans biofilms in intermediate and mature development phases.
    Tobudic S; Lassnigg A; Kratzer C; Graninger W; Presterl E
    Mycoses; 2010 May; 53(3):208-14. PubMed ID: 19298353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Susceptibility of Candida albicans biofilms to caspofungin and anidulafungin is not affected by metabolic activity or biomass production.
    Marcos-Zambrano LJ; Escribano P; Bouza E; Guinea J
    Med Mycol; 2016 Feb; 54(2):155-61. PubMed ID: 26543157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Micafungin at physiological serum concentrations shows antifungal activity against Candida albicans and Candida parapsilosis biofilms.
    Guembe M; Guinea J; Marcos-Zambrano LJ; Fernández-Cruz A; Peláez T; Muñoz P; Bouza E
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5581-4. PubMed ID: 24957821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antifungal susceptibility of Candida species isolated from patients with candidemia in southern Taiwan, 2007-2012: impact of new antifungal breakpoints.
    Chen YC; Kuo SF; Chen FJ; Lee CH
    Mycoses; 2017 Feb; 60(2):89-95. PubMed ID: 27621210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Activity of anidulafungin against Candida biofilms].
    Pemán J; Cantón E; Valentín A
    Rev Iberoam Micol; 2008 Jun; 25(2):124-8. PubMed ID: 18473507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring the In Vitro Resistance of Candida parapsilosis to Echinocandins.
    Chassot F; Venturini TP; Piasentin FB; Rossato L; Fiorini A; Svidzinski TI; Alves SH
    Mycopathologia; 2016 Oct; 181(9-10):663-70. PubMed ID: 27318852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antifungal susceptibility of yeast bloodstream isolates collected during a 10-year period in Austria.
    Beyer R; Spettel K; Zeller I; Lass-Flörl C; Achleitner D; Krause R; Apfalter P; Buzina W; Strauss J; Gregori C; Schüller C; Willinger B
    Mycoses; 2019 Apr; 62(4):357-367. PubMed ID: 30636016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey.
    Dagi HT; Findik D; Senkeles C; Arslan U
    Ann Clin Microbiol Antimicrob; 2016 May; 15(1):36. PubMed ID: 27245756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The calcineurin inhibitor cyclosporin A exhibits synergism with antifungals against Candida parapsilosis species complex.
    Cordeiro RA; Macedo RB; Teixeira CEC; Marques FJF; Bandeira TJPG; Moreira JLB; Brilhante RSN; Rocha MFG; Sidrim JJC
    J Med Microbiol; 2014 Jul; 63(Pt 7):936-944. PubMed ID: 24722799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins.
    Kuhn DM; George T; Chandra J; Mukherjee PK; Ghannoum MA
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1773-80. PubMed ID: 12019089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions between human phagocytes and Candida albicans biofilms alone and in combination with antifungal agents.
    Katragkou A; Kruhlak MJ; Simitsopoulou M; Chatzimoschou A; Taparkou A; Cotten CJ; Paliogianni F; Diza-Mataftsi E; Tsantali C; Walsh TJ; Roilides E
    J Infect Dis; 2010 Jun; 201(12):1941-9. PubMed ID: 20415537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relevance of antifungal penetration in biofilm-associated resistance of Candida albicans and non-albicans Candida species.
    Singh R; Kumari A; Kaur K; Sethi P; Chakrabarti A
    J Med Microbiol; 2018 Jul; 67(7):922-926. PubMed ID: 29767615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EUCAST Reference Testing of Rezafungin Susceptibility and Impact of Choice of Plastic Plates.
    Arendrup MC; Jørgensen KM; Hare RK; Cuenca-Estrella M; Zaragoza O
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31285230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vitro activity of amphotericin B and anidulafungin against Candida spp. biofilms].
    Valentín A; Cantón E; Pemán J; Quindós G
    Rev Iberoam Micol; 2007 Dec; 24(4):272-7. PubMed ID: 18095759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the Sensititre Yeast One microdilution method for susceptibility testing of Candida species to anidulafungin, caspofungin, and micafungin.
    García-Agudo L; García-Martos P; Martos-Cañadas J; Aznar-Marín P; Marín-Casanova P; Rodríguez-Iglesias M
    Rev Esp Quimioter; 2012 Dec; 25(4):256-60. PubMed ID: 23303256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Commercial mouthwashes are more effective than azole antifungals against Candida albicans biofilms in vitro.
    Ramage G; Jose A; Coco B; Rajendran R; Rautemaa R; Murray C; Lappin DF; Bagg J
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Apr; 111(4):456-60. PubMed ID: 21310633
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Arendrup MC; Jørgensen KM; Hare RK; Chowdhary A
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic effect of nikkomycin Z with caspofungin and micafungin against Candida albicans and Candida parapsilosis biofilms.
    Kovács R; Nagy F; Tóth Z; Bozó A; Balázs B; Majoros L
    Lett Appl Microbiol; 2019 Oct; 69(4):271-278. PubMed ID: 31385615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009).
    Pfaller MA; Messer SA; Moet GJ; Jones RN; Castanheira M
    Int J Antimicrob Agents; 2011 Jul; 38(1):65-9. PubMed ID: 21514797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.